BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The inaugural RNA Assay Development and Screening Summit is th
 e only industry-focused RNA assay discovery networking and discussion for
 um\, dedicated to addressing and overcoming challenges drug developers fa
 ce when developing RNA assays and screening tools\, for efficient drug di
 scovery.\n\nDeveloped in collaboration with experts in the field\, this i
 ndustry-focused forum will bring together key opinion leaders to share te
 chnical expertise and discuss data-driven case studies with actionable in
 sights. This event has been curated to support in-house assay development
  and screening strategies to find new RNA targets\, and ultimately determ
 ine biological effect in a manner that supports progression from early di
 scovery to drug candidate.\n\nJoin 60+ experts from assay development\, s
 creening\, pharmacology\, lead discovery and more for exciting data\, int
 eractive learning sessions and networking opportunities to expand and val
 idate your assay and screening strategies to accelerate the path to the c
 linic.\n\nURLs:Tickets:&nbsp\;https://go.evvnt.com/1726754-2?pid=185Broch
 ure:&nbsp\;https://go.evvnt.com/1726754-3?pid=185\n\nPrices:Conference On
 ly - Drug Developers: USD 2999.00\,Conference Only - Academic and Researc
 h Institute: USD 2599.00\,Conference Only - Solution and Service Provider
 : USD 3799.00\n\nSpeakers:&nbsp\;Matthew Disney\, Professor and Chair of 
 Chemistry\, Scripps Research\, Nick Marsh\, Head of Molecular Pharmacolog
 y\, Arrakis Therapeutics\, Wencheng Li\, Director of Bioinformatics\, PTC
  Therapeutics\, Ella Morishita\, Senior Investigator\, Veritas In Silico\
 , May Khanna\, Associate Professor\, New York University\, Matthew Jones\
 , Head of Platform Technology\, NextRNA\, Sam Hasson\, Senior Director\, 
 Rgenta Therapeutics\, Peter Connolly\, Senior Director of Structural Biol
 ogy\, Expansion Therapeutics\, Praveen Kumar\, Director of Biochemistry\,
  Revir Therapeutics\, Nathan Baird\, Associate Professor of Biochemistry\
 , Saint Joseph’s University\, Sarah Woodson\, T.C. Jenkins Professor of B
 iophysics\, Johns Hopkins University\, Matt Smola\, Associate Director of
  RNA Biology\, Ribometrix\, Deepali Gotur\, Senior Scientist\, Lead Disco
 very\, Accent Therapeutics\, Tim Allen\, Head of ChemAI and Vancouver Sit
 e Lead\, Serna Bio\, Eric English\, Associate Scientist\, Luye Pharma\, T
 atsuo Ito\, Founder and Chief Scientific Officer\, CLOVERNA\n\nTime:&nbsp
 \;8:00 am to 4:00 pm\n
DTEND:20230824T160000
DTSTAMP:20260514T153459Z
DTSTART:20230823T080000
LOCATION:The Bostonian Boston\, 26\, North Street\, Boston\, Massachusetts
 \, 02109\,
SEQUENCE:0
SUMMARY:The inaugural RNA Assay Development and Screening Summit is the on
 ly industry-focused RNA assay discovery networking and discussion forum\,
  dedicate...
UID:95a82cc0-a227-46a3-bfd9-935506ce0eb2
END:VEVENT
END:VCALENDAR